Wearable neurostimulation devices market seen reaching $1.22 billion by 2030

The wearable neurostimulation devices market is projected to grow from $0.67 billion in 2025 to $0.75 billion in 2026, then reach $1.22 billion by 2030, according to a new Business Research Company report. Demand is rising as neurological disorders increase, home-based therapies expand and device makers add AI, wireless and mobile health features.

Why it matters: - Wearable neurostimulation devices are moving from niche tools to a broader therapy option for neurological disorders, pain management and home-based care. - The category could benefit from rising demand for non-invasive treatment and more personalized neurological care. - Faster adoption may also help expand access for patients who need portable, easy-to-use treatment outside clinical settings.

What happened: - The Business Research Company released a 2026 market report on wearable neurostimulation devices, covering market size, trends and global forecasts through 2035. - The report values the market at $0.67 billion in 2025 and projects $0.75 billion in 2026. - The report forecasts the market will reach $1.22 billion by 2030. - The report was published Sept. 3, 2026, from London. - A free sample of the report and the full market report are available online.

The details: - The market is forecast to grow at a 13.0% CAGR from 2025 to 2026. - The report expects a 12.8% CAGR from 2026 to 2030. - Growth drivers include rising cases of neurological disorders, greater awareness of non-invasive treatment options and a shift toward home-based therapies. - Technological advances in wearable electronics and expanded clinical research in neuromodulation are also supporting demand. - Looking ahead, the report cites greater investment in digital therapeutics, stronger demand for personalized neurological treatments and wider use of remote patient monitoring. - Integration with mobile health technologies and more regulatory approvals are expected to support additional market entry. - Emerging trends include at-home neurostimulation therapies, wearable brain stimulation devices, AI-powered signal optimization and wireless portable neuro devices focused on personalized neuromodulation. - Wearable neurostimulation devices are compact electronic tools that deliver targeted electrical impulses to the brain or nervous system. - The devices are designed to modulate brain activity to improve cognitive function, relieve pain or help manage conditions including depression, anxiety and chronic pain. - The devices are especially suited for home use because patients can use them with minimal supervision. - That setup can improve convenience and treatment adherence. - Neurological disorders affect the brain, spinal cord and nerves and can cause cognitive, motor and sensory impairments. - Aging is a major factor because it is linked to reduced brain plasticity, impaired neuronal function and oxidative stress. - In June 2024, the U.K. National Health Service reported 487,432 dementia cases, up 3,155 from the previous month.

Between the lines: - The forecast points to a market that is being shaped as much by care delivery changes as by device innovation. - Home-based treatment, remote monitoring and mobile connectivity suggest wearable neurostimulation is becoming part of a broader digital health stack. - North America’s current lead reflects deeper healthcare infrastructure and research capacity, while Asia-Pacific’s growth outlook suggests room for faster adoption as access improves.

What's next: - The report expects Asia-Pacific to post the fastest growth in the coming years. - The market covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics and updated trend analysis. - The company also lists market contacts and social media channels for follow-up.

The bottom line: - Wearable neurostimulation is projected to keep expanding as neurological disease burden rises and patient demand shifts toward portable, personalized, non-invasive treatment.